Effects of glucocorticoids on energy metabolism and food intake in humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 271, Issue 2 34-2, 1996, Pages

  Tataranni, Pietro A ^a   Larson, D Enette ^a   Snitker, Søren ^a   Young, James B ^a   Flatt, J P ^a   Ravussin, Eric ^a  

^a NONE

Author keywords

appetite; hypothalamic pituitary adrenal axis; methylprednisolone; obesity; sympathetic nervous system

Indexed keywords

ADRENALIN; CORTICOTROPIN; FATTY ACID; GLUCOCORTICOID; GLUCOSE; HYDROCORTISONE; INSULIN; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; NORADRENALIN; PLACEBO;

ADRENERGIC SYSTEM; ADULT; APPETITE; ARTICLE; BASAL METABOLIC RATE; CALORIC INTAKE; CALORIMETRY; CATECHOLAMINE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DOUBLE BLIND PROCEDURE; ENERGY BALANCE; ENERGY EXPENDITURE; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; OBESITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN;

EID: 0029778759     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.271.2.e317     Document Type: Article

References (44)

1. Bchini-Hooft van Huijsduijnen, O., F. Rohner-Jeanrenaud, and B. Jeanrenaud. Hypothalamic neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa ) rats; potential regulation thereof by corticotropin-releasing factor. J. Neuroendocrinol. 5: 381-386, 1993.
2. Bessey, P. Q., J. M. Watters, T. T. Aoki, and D. W. Wilmore. Combined hormonal infusion stimulates the metabolic response to injury. Ann. Surg. 200: 264-281, 1984.
3. Bethune, J. E. The diagnosis and treatment of adrenal insufficiency. In: Endocrinology, edited by L. J. De Groot. Philadelphia, PA: Saunders, 1989, p. 1647-1659.
4. Björntorp, P. Adipose tissue distribution and function. Int. J. Obes. 15, Suppl. 2: 67-81, 1991.
5. Bray, G. A. Reciprocal relation between the sympathetic nervous system and food intake. Brain Res. Bull. 27: 517-520, 1991
6. Brillon, D. J., B. Zheng, R. G. Campbell, and D. E. Matthews. Effect of cortisol on energy expenditure and amino acid metabolism in humans. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E501-E513, 1995.
7. Chalew, S., H. Nagel, and S. Shore. The hypothalamic-pituitary-adrenal axis in obesity. Obesity Res. 4: 371-382, 1995.
8. Chong, P. K. K., R. T. Jung, C. M. Scrimgeour, and M. J. Rennie. The effect of pharmacological dosages of glucocorticoids on free living total energy expenditure in man. Clin. Endocrinol. 40: 577-581, 1994.
9. Darmaun, D., D. E. Matthews, and D. M. Bier. Physiological hypercortisolernia increases proteolysis, glutamine, and alanine production. Am. J. Physiol. 255 (Endocrinol Metab. 18): E366-E373, 1988.
10. Dreon, D. M., B. Frey-Hewitt, N. Ellsworth, P. T. Williams, R. B. Terry, and P. D. Wood. Dietary fat: carbohydrate ratio and obesity in middle-aged men. Am. J. Clin. Nutr. 47: 995-1000, 1988.
11. Fain, J. N., V. P. Kovacev, and R. O. Scow. Effects of growth hormone and dexamethasone on lipolysis and metabolism in isolated fat cells of the rat. J. Biol. Chem. 240: 3522-3528, 1965.
12. Felig, P., J. Wharen, and R. Hendler. Influence of maturity-onset diabetes on splanchnic glucose balance after oral glucose ingestion. Diabetes 27: 121-126, 1978.
13. Flatt, J. P. Dietary fat, carbohydrate balance, and weight maintenance. Ann. NY Acad. Sci. 683: 122-140, 1993.
14. Frayn, K. N. Hormonal control of metabolism in trauma and sepsis. Clin. Endocrinol. 24: 577-599, 1983.
15. Goldstein, S. A., and D. H. Elwyn. The effect of injury and sepsis on fuel utilization. Annu. Rev. Nutr. 9: 445-473, 1989.
16. Hauner, H., P. Schmid, and E. F. Pfeiffer. Glucocorticoid and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J. Clin. Endocrinol. Metab. 64: 832-835, 1987.
17. Heinrichs, S. C., F. Menzagui, E. M. Pich, R. L. Hauger, and G. F. Koob. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res. 611: 18-24, 1993.
18. Horber, F. F., H. M. Marsh, and M. W. Raymond. Differential effects of prednisone and growth hormone on fuel metabolism and insulin antagonism in humans. Diabetes 40: 141-149, 1991.
19. Jeanrenaud, F. R. A neuroendocrine reappraisal of the dual-centre hypothesis: its implications for obesity and insulin resistance. Int. J. Obesity 19: 517-534, 1995.
20. Kaiyala, K. J., S. C. Woods, and M. Schwartz. New model of the regulation of energy balance and adiposity by the central nervous system. Am. J. Clin. Nutr. 62: 1123S-1134S, 1995.
21. Kolterman, O. G., J. Insel, M. Saekow, and J. M. Olefsky. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J. Clin. Invest. 65: 1272-1284, 1980.
22. Lamberts, S. W., and J. C. Birkenhager. Body composition in Cushing's disease. J. Clin. Endocrinol. Metab. 42: 864-868, 1976.
23. Langley, S. C., and D. A. York. Effects of the antiglucocorticoid RU 486 on development of obesity in obese fa/fa Zucker rats. Am. J. Physiol. 259 (Regulatory Integrative Comp. Physiol 28) : R539-R544, 1990.
24. Larson, D. E., R. Rising, R. T. Ferraro, and E. Ravussin. Spontaneous overfeeding with a "cafeteria diet" in men: effects on 24-hour energy expenditure and substrate oxidation. Int. J. Obes. 19: 331-337, 1995.
25. 2-drenoceptor function in humans. J. Clin. Endocrinol. Metab. 80: 1804-1808, 1995.
26. MacDonald, I. A., and D. M. Lake. An improved technique for extracting catecholamines from body fluids. J. Neurosci. Methods 13: 239-248, 1985.
27. McGuinness, O. P., D. Neal, D. Bracy, and S. E. Murrel. Glucagon makes a persistent contribution to accelerated glucose metabolism during chronic "stress" hormone infusion (Abstract). Diabetes 38, Suppl. 2: 67A, 1988.
28. McMahon, M., J. Gerich, and R. Rizza. Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab. Rev. 4: 17-30, 1988.
29. Mefford, I. N., M. Ota, M. Stipetic, and W. Singleton. Application of a novel cation-exchange reagent, Igepon T-77 (N-methyl oleoyl taurate), to micropore separations of alumina extracts of catecholamines from cerebrospinal fluid, plasma, urine and brain tissue with amperometric detection. J. Chromatogr. 420: 241-251, 1987.
30. Miles, J., R. Glasscock, J. Aikens, J. Gerich, and M. Haymond. A microfluorometric method for the determination of free fatty acids in plasma. J. Lipid. Res. 24: 96-99, 1983.
31. Muhlbacher, F., C. R. Kapadia, M. F. Colpoys, R. J. Smith, and D. W. Wilmore. Effects of glucocorticoids on glutamine metabolism in skeletal muscle. Am. J. Physiol. 247 (Endocrinol. Metab. 10): E76-E83, 1984.
32. Nelson, D. H. Cushing's syndrome. In: Endocrinology, edited by L. J. De Groot. Philadelphia, PA: Saunders, 1989, p. 1660-1675.
33. Okada, S., D. A. York, and G. A. Bray. Mifepristone (RU 486), a blocker of type II glucocorticoid and progestin receptors, reverses a dietary form of obeaity. Am. J. Physiol. 262 (Regulatory Integrative Comp. Physiol 31): R1106-R1110, 1992.
34. Poricos, K. P., M. F. Esser, and T. B. Van Itallie. Caloric regulation in normal-weight men maintained on a palatable diet of conventional foods Physiol. Behav. 29: 293-300, 1982.
35. Randin, D., P. Vollenwieder, L. Tappy, E. Jequier, P. Nicod, and U. Sherrer. Suppression of alcohol-induced hypertension by dexamethasone. N. Engl. J. Med. 332: 1733-1737, 1995.
36. Ravussin, E., S. Lillioja, T. E. Anderson, L. Christin, and C. Bogardus. Determinants of 24-hour energy expenditure in man. J. Clin. Invest. 78: 1568-1578, 1986.
37. Rebuffe-Scrive, M., M. Krotkiewsky, J. Elfverson, and P. Björntorp. Muscle and adipose tissue morphology and metabolism in Cushing's syndrome. J. Clin. Endocrinol. Metab. 67: 1122-1128, 1988.
38. Rising, R., S. Alger, V. Boyce, H. Seagle, R. Ferraro, A. M. Fontvielle, and E. Ravussin. Food intake measured by an automated food selection system: relationship to energy expenditure. Am. J. Clin. Nutr. 55: 343-349, 1992.
39. Sakaguchi, T., M. Takahashi, and G. A. Bray. Diurnal changes in sympathetic activity; relation to food intake and to insulin injected into the ventromedial and suprachiasmatic nucleus. J. Clin. Invest. 32: 282-286, 1988.
40. Welle, S., and K. S. Nair. Relationship of resting metabolic rate to body composition and protein turnover. Am. J. Physiol. 258 (Endocrinol. Metab. 21): E990-E998, 1990.
41. Willox, J. C., J. Corr, J. Shaw, M. Richardson, and K. Calman. Prednisolone as an appetite stimulant in patients with cancer. Br. Med. J. 288: 27, 1984.
42. York, D. A., S. J. Holt, J. Allars, and J. Payne. Glucocorticoids and the central control of sympathetic activity in the obese fa/fa rat. In: Obesity in Europe 88, edited by P. Björntorp and S. Rossner. London: Libbey, 1988, p 247-252.
43. Young, J. B., and L. Landsberg. Suppression of sympathetic nervous system during fasting. Science Wash. DC 196: 1473-1475, 1977.
44. Young, J. B., and L. Landsberg. Stimulation of the sympathetic nervous system during sucrose feeding. Nature Lond. 269: 615-617, 1977.